# Tevogen Inc. (TVGN)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/tevogen-inc/ JSON: https://steadybase.io/company/tevogen-inc.json Checked Nov 21, 2026. Latest filing read: Nov 17, 2026.

## Company

- Legal name: Tevogen Inc.
- Ticker: TVGN, TVGNW (Nasdaq, Nasdaq)
- SEC CIK: 0001860871
- Industry: Biological Products, (No Diagnostic Substances) (SIC 2836)
- Headquarters: Warren, NJ
- Fiscal year ends: December 31
- SEC filer category: <br>Emerging growth company
- Website: tevogen.com
- LinkedIn: https://www.linkedin.com/company/tevogen-bio
- Next earnings date: Feb 12, 2027

## Key facts

- Operating income: -$26.1M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 31, 2026). Source: https://www.sec.gov/Archives/edgar/data/1860871/000149315226014326/0001493152-26-014326-index.html
- Net income: -$26.3M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 31, 2026). Source: https://www.sec.gov/Archives/edgar/data/1860871/000149315226014326/0001493152-26-014326-index.html
- SG&A: $15.0M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 31, 2026). Source: https://www.sec.gov/Archives/edgar/data/1860871/000149315226014326/0001493152-26-014326-index.html
- Shares outstanding: 68,678,743 as of Nov 16, 2026 (10-Q filed Nov 16, 2026). Source: https://www.sec.gov/Archives/edgar/data/1860871/000149315226052607/0001493152-26-052607-index.html
- Auditor: Kpmg LLP, Philadelphia, Pennsylvania, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1860871/000149315226014326/form10-k.htm

## Business

Tevogen is a healthcare company focused on addressing unmet needs across biotechnology, technology, and healthcare services.

Source: Company website description, https://tevogen.com/

## Officers and directors

- Ryan H. Saadi, Chief Executive Officer. Source: Form 4 filed Sep 16, 2026, https://www.sec.gov/Archives/edgar/data/1860871/000112329226001313/0001123292-26-001313-index.htm
- Ryan Saadi, Chief Executive Officer and Chairperson of the Company's Board of Directors. Source: 8-K filed Sep 16, 2026, https://www.sec.gov/Archives/edgar/data/1860871/000149315226042952/form8-k.htm
- Kirti Desai, Chief Financial Officer. LinkedIn: https://www.linkedin.com/in/kirti-desai-198136221. Source: 8-K filed Sep 16, 2026, https://www.sec.gov/Archives/edgar/data/1860871/000149315226042952/form8-k.htm
- Jeffrey Feike, Board member (per proxy). Source: DEF 14A filed Aug 3, 2026, https://www.sec.gov/Archives/edgar/data/1860871/000149315226035757/formdef14a.htm
- Neal Flomenberg, Named in proxy. Source: DEF 14A filed Aug 3, 2026, https://www.sec.gov/Archives/edgar/data/1860871/000149315226035757/formdef14a.htm
- Susan Podlogar, Board member (per proxy). Source: DEF 14A filed Aug 3, 2026, https://www.sec.gov/Archives/edgar/data/1860871/000149315226035757/formdef14a.htm
- Victor Sordillo, Board member (per proxy). Source: DEF 14A filed Aug 3, 2026, https://www.sec.gov/Archives/edgar/data/1860871/000149315226035757/formdef14a.htm

## Recent 8-K events

- Nov 4, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1860871/000149315226049903/form8-k.htm
- Nov 3, 2026: Item 1.01, Entry into a material definitive agreement; Item 2.03, Creation of a direct financial obligation; Item 3.02, Unregistered sales of equity securities; Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1860871/000149315226049649/form8-k.htm
- Sep 30, 2026: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1860871/000149315226045123/form8-k.htm
- Sep 16, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1860871/000149315226042952/form8-k.htm
- Sep 10, 2026: Item 8.01, Other events. Source: https://www.sec.gov/Archives/edgar/data/1860871/000149315226042095/form8-k.htm
- Aug 26, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 5.07, Submission of matters to a vote of security holders; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1860871/000149315226040216/form8-k.htm
- Jul 30, 2026: Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1860871/000149315226035334/form8-k.htm
- Apr 22, 2026: Item 3.01, Notice of delisting or failure to meet listing standards. Source: https://www.sec.gov/Archives/edgar/data/1860871/000149315226018590/form8-k.htm
- Mar 25, 2026: Item 8.01, Other events. Source: https://www.sec.gov/Archives/edgar/data/1860871/000149315226012701/form8-k.htm
- Mar 4, 2026: Item 3.03, Material modification to rights of security holders; Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1860871/000149315226008786/form8-k.htm

## Insider trades (Form 4)

- Mar 13, 2026: Neal Flomenberg (See Remarks) sold 972 shares, about $6,635. Source: https://www.sec.gov/Archives/edgar/data/1860871/000112329226000465/0001123292-26-000465-index.htm

## Latest filings

- 8-K filed Nov 3, 2026: https://www.sec.gov/Archives/edgar/data/1860871/000149315226049649/form8-k.htm
- 10-K filed Mar 31, 2026: https://www.sec.gov/Archives/edgar/data/1860871/000149315226014326/form10-k.htm
- 10-Q filed Aug 14, 2026: https://www.sec.gov/Archives/edgar/data/1860871/000149315226038509/form10-q.htm
- DEF 14A filed Aug 3, 2026: https://www.sec.gov/Archives/edgar/data/1860871/000149315226035757/formdef14a.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/

